Arama Sonuçları - Andrea Casadei‐Gardini

Sonuçları Daraltın
  1. 1
    Oxidative Molecular Mechanisms Underlying Liver Diseases: From Systems Biology to the Personalized Medicine

    Oxidative Molecular Mechanisms Underlying Liver Diseases: From Systems Biology to the Personalized Medicine Yazar: Daniele Vergara, Andrea Casadei‐Gardini, Anna Maria Giudetti

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Editorial
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials

    Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials Yazar: Andrea Casadei‐Gardini, Emiliano Tamburini, Mercedes Iñarrairaegui, Giovanni Luca Frassineti, Bruno Sangro

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Early gastric cancer: diagnosis, staging, and clinical impact. Evaluation of 530 patients. New elements for an updated definition and classification

    Early gastric cancer: diagnosis, staging, and clinical impact. Evaluation of 530 patients. New elements for an updated definition and classification Yazar: Luca Saragoni, Paolo Morgagni, Andrea Casadei‐Gardini, Caterina Marfisi, Giovanni Vittimberga, Domenico Garcea, Emanuela Scarpi

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Long-term and short-term prognostic value of the prognostic nutritional index in cancer: a narrative review

    Long-term and short-term prognostic value of the prognostic nutritional index in cancer: a narrative review Yazar: Yan Li, Tomoki Nakamura, Andrea Casadei‐Gardini, Gema Bruixola, Yuan‐Lan Huang, Zhi-De Hu

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities

    Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities Yazar: Serena De Matteis, Andrea Ragusa, Giorgia Marisi, Stefania De Domenico, Andrea Casadei‐Gardini, Massimiliano Bonafè, Anna Maria Giudetti

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  6. 6
    BRAF-Mutated Colorectal Cancer: Clinical and Molecular Insights

    BRAF-Mutated Colorectal Cancer: Clinical and Molecular Insights Yazar: Francesco Caputo, Chiara Santini, Camilla Bardasi, Krisida Cerma, Andrea Casadei‐Gardini, Andrea Spallanzani, Kalliopi Andrikou, Stefano Cascinu, Fabio Gelsomino

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities

    Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities Yazar: Matteo Canale, Andrea Casadei‐Gardini, Paola Ulivi, María Arechederra, Carmen Berasain, Pier‐Luigi Lollini, Maite G. Fernández‐Barrena, Matías A. Ávila

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New

    Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New Yazar: Luca Faloppi, Maristella Bianconi, Riccardo Memeo, Andrea Casadei‐Gardini, Riccardo Giampieri, Alessandro Bittoni, Kalliopi Andrikou, Michela Del Prete, Stefano Cascinu, Mario Scartozzi

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients

    Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients Yazar: Francesco Tovoli, Luca Ielasi, Andrea Casadei‐Gardini, Alessandro Granito, Francesco Giuseppe Foschi, Giulia Rovesti, Giulia Negrini, Giulia Orsi, Matteo Renzulli, Fabio Piscaglia

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib

    Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib Yazar: Oronzo Brunetti, Antonio Gnoni, Antonella Licchetta, Vito Longo, Angela Calabrese, Antonella Argentiero, Sabina Delcuratolo, Antonio Giovanni Solimando, Andrea Casadei‐Gardini, Nicola Silvestris

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  11. 11
    EGFR, HER-2 and KRAS in Canine Gastric Epithelial Tumors: A Potential Human Model?

    EGFR, HER-2 and KRAS in Canine Gastric Epithelial Tumors: A Potential Human Model? Yazar: Rossella Terragni, Andrea Casadei‐Gardini, Silvia Sabattini, Giuliano Bettini, Dino Amadori, Chiara Talamonti, Massimo Vignoli, Laura Capelli, Jimmy Saunders, Marianna Ricci, Paola Ulivi

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report

    Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report Yazar: Andrea Casadei‐Gardini, Elisa Chiadini, Luca Faloppi, Giorgia Marisi, Angelo Delmonte, Mario Scartozzi, Cristian Loretelli, Alessandro Lucchesi, Devil Oboldi, Alessandra Dubini, Giovanni Luca Frassineti, Paola Ulivi

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)

    KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC) Yazar: Andrea Casadei‐Gardini, Laura Capelli, Paola Ulivi, Massimo Carlo Giannini, Eva Freier, Stefano Tamberi, Emanuela Scarpi, Alessandro Passardi, Wainer Zoli, Angela Ragazzini, Dino Amadori, Giovanni Luca Frassineti

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Immunotherapeutic approaches for hepatocellular carcinoma

    Immunotherapeutic approaches for hepatocellular carcinoma Yazar: Vito Longo, Antonio Gnoni, Andrea Casadei‐Gardini, Salvatore Pisconti, Antonella Licchetta, Mario Scartozzi, Riccardo Memeo, Vincenzo Ostilio Palmieri, Giuseppe Aprile, Daniele Santini, Patrizia Nardulli, Nicola Silvestris, Oronzo Brunetti

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy

    Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy Yazar: Paola Ulivi, Emanuela Scarpi, Elisa Chiadini, Giorgia Marisi, Martina Valgiusti, Laura Capelli, Andrea Casadei‐Gardini, Manlio Monti, Silvia Ruscelli, Giovanni Luca Frassineti, Daniele Calistri, Dino Amadori, Alessandro Passardi

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib

    Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib Yazar: Andrea Casadei‐Gardini, Emanuela Scarpi, Luca Faloppi, Mario Scartozzi, Nicola Silvestris, Daniele Santini, G. de Stefano, Giorgia Marisi, Francesca Negri, Francesco Giuseppe Foschi, Martina Valgiusti, Giorgio Ercolani, Giovanni Luca Frassineti

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?

    Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers? Yazar: Giorgia Marisi, Alessandro Cucchetti, Paola Ulivi, Matteo Canale, Giuseppe Cabibbo, Leonardo Solaini, Francesco Giuseppe Foschi, Serena De Matteis, Giorgio Ercolani, Martina Valgiusti, Giovanni Luca Frassineti, Mario Scartozzi, Andrea Casadei‐Gardini

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  18. 18
    1H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages

    1H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages Yazar: Andrea Casadei‐Gardini, Laura Del Coco, Giorgia Marisi, Fabio Conti, Giulia Rovesti, Paola Ulivi, Matteo Canale, Giovanni Luca Frassineti, Francesco Giuseppe Foschi, Serena Longo, Francesco Paolo Fanizzi, Anna Maria Giudetti

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Sarcopenia in gastric cancer: when the loss costs too much

    Sarcopenia in gastric cancer: when the loss costs too much Yazar: Elena Ongaro, Vanessa Buoro, M. Cinausero, Riccardo Caccialanza, Annalisa Turri, V. Fanotto, Debora Basile, Maria Grazia Vitale, Paola Ermacora, Giovanni Gerardo Cardellino, Laura Nicoletti, Lorenzo Fornaro, Andrea Casadei‐Gardini, Giuseppe Aprile

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  20. 20
    EUS-guided gastroenterostomy for management of malignant gastric outlet obstruction: a prospective cohort study with matched comparison with enteral stenting

    EUS-guided gastroenterostomy for management of malignant gastric outlet obstruction: a prospective cohort study with matched comparison with enteral stenting Yazar: Giuseppe Vanella, Giuseppe Dell’Anna, Gabriele Capurso, Patrick Maisonneuve, Michiel Bronswijk, Stefano Crippa, Domenico Tamburrino, Marina Macchini, Giulia Orsi, Andrea Casadei‐Gardini, Luca Aldrighetti, Michele Reni, Massimo Falconi, Van der Merwe, Paolo Giorgio Arcidiacono

    Baskı/Yayın Bilgisi 2023
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: